References
Adams RD, Victor M, Ropper AH (1997) Infections of the central nervous system. Principles of neurology. McGraw Hill, New York
Hoitsma E, Faber CG, Drent M et al (2004) Neurosarcoidosis: a clinical dilemma. Lancet 3:397–405
Nowak DA, Widenka DC (2001) Neurosarcoidosis: a review of its intracranial manifestation. J Neurol 248:363–372
Lower EE, Wiess KL (2008) Neurosarcoidosis. Clin Chest Med 29:475–492
Moller DR (2003) Treatment of sarcoidosis from a basic point of view. J Intern Med 253:31–40
Santos E et al (2010) Treatment of refractory neurosarcoidosis with Infliximab. J Neurol Neurosurg Psychiatr 81:241–246
Moravan M, Segal BM (2009) Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 72:337–340
Tong D, Manolios N et al (2012) New-onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognized complication. Intern Med J 42(1):89–94
Daien CI, Monnier A, Claudepierre P et al (2009) Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology 48(8):883–886
Massara A, Cavazzini L, La Corte R, Trotta F (2010) Sarcoidosis appearing during anti-tumor necrosis factor alpha: a new “class effect” Paradoxical Phenomenon. Semin Arthritis Rheum 39:313–319
Sturfelt G, Christensson B et al (2007) Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab. J Rheumatol 34:2313–2314
Ramos-Casal M, Roberto-Perez-Alvarez, Diaz-Lagares C, Cuadrado M-J, Khamashta MA, and BIOGEAS Study Group (2010) Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 9:188.193
Solomon AJ, Spain RI, Kruer MC, Bourdette D (2011) Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Mult Scler 17(12):1472–1487
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mao-Draayer, Y., Cash, T. Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitors. J Neurol 260, 651–653 (2013). https://doi.org/10.1007/s00415-012-6726-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-012-6726-9